Rhenman & Partners Asset Management Ab Portfolio Holdings

Rhenman & Partners Asset Management Ab

  • $1.2 Billion
  • Q3 2024

Rhenman & Partners Asset Management Ab has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.2 Billion distributed in 95 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $49.4M, Unitedhealth Group Inc with a value of $42.5M, Eli Lilly & CO with a value of $42.1M, Regeneron Pharmaceuticals, Inc. with a value of $41M, and Tenet Healthcare Corp with a value of $36.8M.

Examining the 13F form we can see an increase of $188M in the current position value, from $1.01B to 1.2B.

Rhenman & Partners Asset Management Ab is based out at Stockholm, V7

Below you can find more details about Rhenman & Partners Asset Management Ab portfolio as well as his latest detailed transactions.

Portfolio value $1.2 Billion
Healthcare: $1.2 Billion
Basic Materials: $1.14 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 95
  • Current Value $1.2 Billion
  • Prior Value $1.01 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 8 stocks
  • Additional Purchases 39 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 39 stocks
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email